Sex Hormones in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis
Abstract
For decades, it has been known that females are more susceptible than males to multiple sclerosis (MS). It has also long been appreciated that during late pregnancy there is a decrease in MS disease activity. Interestingly, these two observations have also been made in an extensively used animal model for MS, experimental autoimmune encephalomyelitis (EAE) in SJL mice. Female mice are more susceptible to disease than male mice, and there is an improvement in disease during late pregnancy. In this review, the role of sex hormones in each of these two observations is characterized in this EAE model using castration and exogenous hormone treatment strategies. The gender difference in EAE susceptibility is due primarily to a protective effect of testosterone in male mice. The decrease in disease severity during late pregnancy appears to be due at least in part to high levels of estriol, which characterize this time period.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A decrease in the severity of symptoms in comparison with a nonpregnant control group was detected in pregnant mice affected by experimental autoimmune encephalomyelitis.
“Similarly, a decrease in the severity of the symptoms in comparison with a nonpregnant control group was detected in pregnant mice affected by experimental autoimmune encephalomyelitis, a model of the autoimmune destruction of myelin sheaths occurring in MS48.”
From Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system (2016) · cites this paper as [48]
The citation lists haven’t been fetched yet
References 66 · Cited by 158
- Authors
- Voskuhl, R. R., & Palaszynski, K.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Voskuhl, Rhonda R.
- ORCID
- Voskuhl, Rhonda R.
- Venue
- The Neuroscientist
- Publisher
- SAGE Publications
- Published
- 2001-06
- Volume
- 7
- Issue
- 3
- Pages
- 258-270
- ISSN
- 1073-8584 (ISSN-L)
- 1089-4098
- OpenAlex
- W2149511379
- Cited by
- 158
- References
- 66
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 7 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 13 · 2015: 8 · 2014: 9 · 2013: 7 · 2012: 11
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Neuroscientist (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns036680-02)
- National Institute of Neurological Disorders and Stroke (NS36680)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- sex hormones, experimental autoimmune encephalomyelitis, multiple sclerosis, sex differences in disease susceptibility, testosterone, estriol, pregnancy, castration, hormone replacement therapy, SJL mice
- MeSH terms
- Animals, Encephalomyelitis, Autoimmune, Experimental, Female, Humans, Male, Multiple Sclerosis, Sex Factors, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review